Anidro Do Brasil Extracoes Sa, based in Brazil, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PILOCARPINE HYDROCHLORIDE USP, with a corresponding US DMF Number 10025.
Remarkably, this DMF maintains an Active status since its submission on December 28, 1992, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 17, 2017, and payment made on February 22, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II